Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.34 USD | -0.93% | +6.80% | +6.59% |
07-11 | Abeona Therapeutics Partners with Beacon Therapeutics to Develop Ophthalmic Gene Therapies | MT |
07-11 | Abeona Therapeutics Inc. and Beacon Therapeutics Announce Non-Exclusive Agreement | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.59% | 221M | |
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Abeona Therapeutics Partners with Beacon Therapeutics to Develop Ophthalmic Gene Therapies